Merz Therapeutics is a pioneering biotechnology company specializing in innovative treatments for neurological disorders. With a commitment to expanding its portfolio and global reach, Merz Therapeutics aims to transform the lives of patients through advanced therapeutic solutions. The company is particularly focused on specialty neurology, where its expertise and research pipeline strive to address unmet medical needs.

Guided by a rich history of neurological innovation, Merz Therapeutics is actively developing cutting-edge medicines while fostering strategic partnerships with biopharmaceutical companies and neuroscience innovators. This collaborative approach is integral to their mission of delivering improved health outcomes for patients worldwide. In addition to neurology, Merz also explores therapeutic developments in hepatology and dermatology.

Dedicated to sustainability, Merz Therapeutics integrates environmental stewardship into its operations, ensuring that human health and ecological health are prioritized. With a passionate management team and a culture focused on patient well-being, Merz Therapeutics stands at the forefront of healthcare innovation.